Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

Dian Wang, Qiang Zhang, Charles D. Blanke, George D. Demetri, Michael C. Heinrich, James C. Watson, John P. Hoffman, Scott Heitaka Okuno, John M. Kane, Margaret Von Mehren, Burton L. Eisenberg

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)2420
Number of pages1
JournalAnnals of Surgical Oncology
Volume19
Issue number7
DOIs
StatePublished - Jul 2012

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Erratum : Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5). / Wang, Dian; Zhang, Qiang; Blanke, Charles D.; Demetri, George D.; Heinrich, Michael C.; Watson, James C.; Hoffman, John P.; Okuno, Scott Heitaka; Kane, John M.; Von Mehren, Margaret; Eisenberg, Burton L.

In: Annals of Surgical Oncology, Vol. 19, No. 7, 07.2012, p. 2420.

Research output: Contribution to journalArticle

Wang, Dian ; Zhang, Qiang ; Blanke, Charles D. ; Demetri, George D. ; Heinrich, Michael C. ; Watson, James C. ; Hoffman, John P. ; Okuno, Scott Heitaka ; Kane, John M. ; Von Mehren, Margaret ; Eisenberg, Burton L. / Erratum : Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5). In: Annals of Surgical Oncology. 2012 ; Vol. 19, No. 7. pp. 2420.
@article{01cb2bf2650242939a8a03d574573e68,
title = "Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)",
author = "Dian Wang and Qiang Zhang and Blanke, {Charles D.} and Demetri, {George D.} and Heinrich, {Michael C.} and Watson, {James C.} and Hoffman, {John P.} and Okuno, {Scott Heitaka} and Kane, {John M.} and {Von Mehren}, Margaret and Eisenberg, {Burton L.}",
year = "2012",
month = "7",
doi = "10.1245/s10434-012-2228-3",
language = "English (US)",
volume = "19",
pages = "2420",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - Erratum

T2 - Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

AU - Wang, Dian

AU - Zhang, Qiang

AU - Blanke, Charles D.

AU - Demetri, George D.

AU - Heinrich, Michael C.

AU - Watson, James C.

AU - Hoffman, John P.

AU - Okuno, Scott Heitaka

AU - Kane, John M.

AU - Von Mehren, Margaret

AU - Eisenberg, Burton L.

PY - 2012/7

Y1 - 2012/7

UR - http://www.scopus.com/inward/record.url?scp=84865152211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865152211&partnerID=8YFLogxK

U2 - 10.1245/s10434-012-2228-3

DO - 10.1245/s10434-012-2228-3

M3 - Article

AN - SCOPUS:84865152211

VL - 19

SP - 2420

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 7

ER -